Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Jul 8, 2015

Aethlon Medical Announces Nasdaq Capital Market Listing Approval

Jun 24, 2015

Aethlon Medical Announces $6 Million Equity Investment

Jun 11, 2015

Aethlon Medical Discloses Upcoming Presentations

Jun 9, 2015

Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements

Jun 5, 2015

Aethlon Medical to Present at the BIO International Convention

Jun 4, 2015

Aethlon Medical Expands Clinical Research Studies to Include Chikungunya Virus

May 26, 2015

Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference

May 13, 2015

Aethlon Medical Announces Health Canada Approval of Ebola Treatment Protocol

May 12, 2015

Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study

May 4, 2015

Aethlon Medical Announces Withdrawal of S-1 Registration Statement

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.